Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IMA-026 Administered Subcutaneously or Intravenously to Healthy Japanese Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2009
At a glance
- Drugs IMA 026; IMA 026
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- 24 Jul 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2008 New trial record.